The added value of diffusion-weighted images and dynamic contrast-enhancement in multi-parametric MRI for the detection of clinically significant prostate cancer in the PICTURE trial

Autor: Eldred-Evans, D, Neves, JB, Simmons, LAM, Kanthabalan, A, McCartan, N, Shah, TT, Arya, M, Charman, SC, Freeman, A, Moore, CM, Punwani, S, Emberton, M, Ahmed, HU

OBJECTIVE: To determine the additional diagnostic value of diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (DCE) imaging in men requiring a repeat biopsy within the PICTURE study. PATIENTS AND METHODS: PICTURE was a paired-cohort confi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1032::0c9ec4e071a99312e68f2fa9f881eda1
http://hdl.handle.net/10044/1/75469

Added value of diffusion-weighted images and dynamic contrast enhancement in multiparametric magnetic resonance imaging for the detection of clinically significant prostate cancer in the PICTURE trial.

Autor: Eldred-Evans D; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Department of Urology, Imperial College Healthcare NHS Trust, London, UK., Neves JB; Division of Surgery and Interventional Science, University College London, Faculty of Medical Sciences, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, UK., Simmons LAM; Division of Surgery and Interventional Science, University College London, Faculty of Medical Sciences, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, UK., Kanthabalan A; Division of Surgery and Interventional Science, University College London, Faculty of Medical Sciences, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, UK., McCartan N; Division of Surgery and Interventional Science, University College London, Faculty of Medical Sciences, London, UK., Shah TT; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Department of Urology, Imperial College Healthcare NHS Trust, London, UK.; Division of Surgery and Interventional Science, University College London, Faculty of Medical Sciences, London, UK., Arya M; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Department of Urology, Imperial College Healthcare NHS Trust, London, UK.; Division of Surgery and Interventional Science, University College London, Faculty of Medical Sciences, London, UK., Charman SC; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, UK.; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, UK., Freeman A; Department of Pathology, UCLH NHS Foundation Trust, London, UK., Moore CM; Division of Surgery and Interventional Science, University College London, Faculty of Medical Sciences, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, UK., Punwani S; Department of Radiology, UCLH NHS Foundation Trust, London, UK.; Centre for Medical Imaging, Division of Medicine, Faculty of Medical Sciences, University College London, London, UK., Emberton M; Division of Surgery and Interventional Science, University College London, Faculty of Medical Sciences, London, UK.; Department of Urology, UCLH NHS Foundation Trust, London, UK., Ahmed HU; Imperial Prostate, Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, UK.; Department of Urology, Imperial College Healthcare NHS Trust, London, UK.; Division of Surgery and Interventional Science, University College London, Faculty of Medical Sciences, London, UK.

Publikováno v: BJU international [BJU Int] 2020 Mar; Vol. 125 (3), pp. 391-398. Date of Electronic Publication: 2019 Dec 11.

Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists.

Autor: Antonelli M; Centre for Medical Image Computing, University College London, London, UK.; School of Biomedical Engineering and Imaging Science, King's College London, London, UK., Johnston EW; Centre for Medical Imaging, University College London, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK., Dikaios N; Centre for Medical Imaging, University College London, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK., Cheung KK; Centre for Medical Imaging, University College London, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK., Sidhu HS; Centre for Medical Imaging, University College London, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK., Appayya MB; Centre for Medical Imaging, University College London, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK., Giganti F; Department of Radiology, University College London Hospital, London, UK.; Division of Surgery and Interventional Science, University College London, London, UK., Simmons LAM; Division of Surgery and Interventional Science, University College London, London, UK., Freeman A; Department of Pathology, University College London Hospital, London, UK., Allen C; Department of Radiology, University College London Hospital, London, UK., Ahmed HU; Division of Surgery and Interventional Science, University College London, London, UK., Atkinson D; Centre for Medical Imaging, University College London, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK., Ourselin S; School of Biomedical Engineering and Imaging Science, King's College London, London, UK., Punwani S; Centre for Medical Imaging, University College London, 2nd Floor Charles Bell House, 43-45 Foley Street, London, W1W 7TS, UK. shonit.punwani@gmail.com.; Department of Radiology, University College London Hospital, London, UK. shonit.punwani@gmail.com.

Publikováno v: European radiology [Eur Radiol] 2019 Sep; Vol. 29 (9), pp. 4754-4764. Date of Electronic Publication: 2019 Jun 11.

Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.

Autor: Olivier J; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, Hospital Huriez, University Lille Nord de France, Lille, France.; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom., Stavrinides V; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom., Kay J; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom., Freeman A; Department of Pathology, UCLH NHS Foundation Trust, London, United Kingdom., Pye H; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom., Ahmed Z; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom., Carmona Echeverria L; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom., Heavey S; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom., Simmons LAM; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom., Kanthabalan A; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom., Arya M; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom., Briggs T; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom.; Department of Urology, The Royal Free London NHS Foundation Trust, London, United Kingdom., Barratt D; Department of Computer Science, Centre for Medical Imaging and Computing, University College London, London, United Kingdom., Charman SC; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom.; Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom., Gelister J; Department of Urology, The Royal Free London NHS Foundation Trust, London, United Kingdom., Hawkes D; Department of Computer Science, Centre for Medical Imaging and Computing, University College London, London, United Kingdom., Hu Y; Department of Computer Science, Centre for Medical Imaging and Computing, University College London, London, United Kingdom., Jameson C; Department of Pathology, UCLH NHS Foundation Trust, London, United Kingdom., McCartan N; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom., Punwani S; Faculty of Medicine, Department of Radiology, UCLH NHS Foundation Trust, London, United Kingdom., van der Muelen J; Department of Pathology, UCLH NHS Foundation Trust, London, United Kingdom.; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom., Moore C; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom., Emberton M; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom., Ahmed HU; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Division of Surgery, Department of Surgery and Cancer, Imperial College London, London, United Kingdom.; Imperial Urology, Charing Cross Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom., Whitaker HC; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.

Publikováno v: The Prostate [Prostate] 2018 Dec; Vol. 78 (16), pp. 1229-1237. Date of Electronic Publication: 2018 Aug 02.

Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study.

Autor: Miah S; Division of Surgery and Interventional Science, University College London, London, United Kingdom; Department of Urology, Charing Cross, Imperial Healthcare NHS Trust, London, United Kingdom. Electronic address: saiful.miah@ucl.ac.uk., Eldred-Evans D; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom., Simmons LAM; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Shah TT; Department of Urology, Charing Cross, Imperial Healthcare NHS Trust, London, United Kingdom., Kanthabalan A; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Arya M; Department of Urology, University College London Hospital, London, United Kingdom., Winkler M; Department of Urology, Charing Cross, Imperial Healthcare NHS Trust, London, United Kingdom., McCartan N; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Freeman A; Department of Pathology, University College London Hospital, London, United Kingdom., Punwani S; Department of Radiology, University College London Hospital, London, United Kingdom., Moore CM; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Emberton M; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Ahmed HU; Department of Urology, Charing Cross, Imperial Healthcare NHS Trust, London, United Kingdom; Division of Surgery, Department of Surgery and Cancer, Faculty of Medicine, Imperial College London, London, United Kingdom.

Publikováno v: The Journal of urology [J Urol] 2018 Dec; Vol. 200 (6), pp. 1235-1240. Date of Electronic Publication: 2018 Jun 27.